All the news Showing 10 of 847 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Sexual transmission Reinfection after hepatitis C cure predicted by sexually transmitted infections Keith Alcorn / 07 April 2021 Screening for sexually transmitted infections in people coinfected with HIV and hepatitis C during or shortly after completing direct-acting antiviral treatment to cure hepatitis C may predict which patients are at higher risk ... Testing for hepatitis C Outreach to homeless in England achieved large-scale testing for hepatitis C during the COVID-19 lockdown Keith Alcorn / 25 March 2021 Outreach to homeless people in England housed in temporary accommodation during the COVID-19 pandemic led to over 1200 to be tested for hepatitis C, one in ten to test positive for active ... Hepatitis C elimination 12 good practices that should be part of the hepatitis C standard of care Keith Alcorn / 25 March 2021 Hepatitis C programmes and health services should review whether they are using best practices in diagnosis, treatment and care of people with hepatitis C, and update service models to improve hepatitis C elimination ... Hepatocellular carcinoma (HCC) Pancreatic and colorectal cancer risk raised in people with hepatitis C Keith Alcorn / 16 March 2021 Pancreatic cancer occurred more often in people with hepatitis C or HIV in Canada’s British Columbia Hepatitis Testers Cohort, and colorectal cancer was more likely to occur in people diagnosed with hepatitis ... HBV treatment for people with HIV People with HIV and hepatitis B should have ongoing monitoring for liver cancer Liz Highleyman / 15 March 2021 People with HIV and hepatitis B co-infection remain at risk for developing hepatocellular carcinoma (HCC) despite antiviral treatment and should undergo regular monitoring for liver cancer, according to research presented ... Coronavirus COVID-19 slows viral hepatitis elimination, global survey finds Keith Alcorn / 22 February 2021 COVID-19 has caused substantial disruption to viral hepatitis screening and treatment, a global survey finds, but has also led to improvements in laboratory capacity and telemedicine that will benefit future efforts to eliminate ... Coronavirus Hepatitis C does not raise the risk of death from COVID-19 Keith Alcorn / 19 February 2021 People with hepatitis C were more likely to be admitted to hospital as a result of SARS-CoV-2 infection but no more likely to die when compared to people without hepatitis C of ... Diabetes & HCV Hepatitis C treatment reduces stroke and heart attack risk Keith Alcorn / 18 February 2021 Hepatitis C treatment reduces the risk of subsequent stroke or heart attack by between 25 and 35%, a meta-analysis of studies published in the Journal of Viral Hepatitis shows. People with hepatitis C ... Injecting drug use Hepatitis C declining among drug users in UK Keith Alcorn / 11 February 2021 The prevalence of hepatitis C in people who inject drugs has fallen modestly in England, Wales and Northern Ireland and sharply in Scotland since 2016, Public Health England reports. Around one in four ... Adherence to treatment High adherence and hepatitis C cure rates in active drug and alcohol users Keith Alcorn / 04 February 2021 People who use drugs achieved high rates of hepatitis C cure on direct-acting antiviral treatment despite ongoing drug and alcohol use, demonstrating that active drug use should not be a barrier to ... ← First12345...85Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds